PubMed · 10701921
LC method development for ibuprophen and validation in different pharmaceuticals.
Abstract
An isocratic LC method for the simultaneous determination of ibuprophen (IBU) and its degradation product (4-isobutylacetophenone) has been developed and validated for different pharmaceuticals (sachets, tablets and gels). The chromatographic separation was achieved with phosphoric acid solution (pH 3.2)-acetonitrile (50:50, v/v) as mobile phase, a Hypersil C18 column and UV detection at 254 nm. In all cases, sample preparation was required before HPLC analysis.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A I Gasco-Lopez, R Izquierdo-Hornillos, A Jimenez. 1999. LC method development for ibuprophen and validation in different pharmaceuticals.. https://doi.org/10.1016/s0731-7085(99)00127-2. https://pubmed.health/record/pubmed%3A10701921/lc-method-development-for-ibuprophen-and-validation-in-different-pharmaceuticals
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.